-

NEUROPACE, INC. INVESTIGATION: NPCE Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against NeuroPace, Inc. (“NeuroPace” or the “Company”) (NASDAQ: NPCE). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired NeuroPace securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to learn more about your rights.

[LEARN MORE ABOUT POTENTIAL SECURITIES FRAUD CLAIMS]

What Happened?

On November 13, 2026, NeuroPace released its third quarter 2026 financial results, announcing third quarter revenue of $23.1 million, a 1.1% decline year-over-year, and cutting its full year 2026 revenue guidance to $91 million to $92 million, down from $99.5 million to $101.5 million. NeuroPace CEO Joel Becker stated, “Our third quarter results fell short of our expectations,” attributing those results to “local operational issues” (such as staffing, physician availability, and diagnostic procedure capacity) at “several of our largest accounts,” as well as sales force disruption and the continued impact of the Company’s exit from the stereoelectroencephalography (“SEEG”) distribution business. Just three months earlier, on August 11, 2026, NeuroPace increased its full-year 2026 revenue guidance to $99.5 million to $101.5 million, up from $99 million to $101 million. In August, CFO Patrick Williams stated, “The increase in total revenue guidance reflects improved visibility into service revenue, which we now expect to be approximately $1 million for the full year, up from previous guidance of $500,000… We expect our third quarter RNS revenue growth to be similar to our first half RNS growth rate of approximately 20% year-over-year.” On the November news, the price of NeuroPace shares declined by $4.46 per share, or approximately 37.1%, from $12.02 per share on November 12, 2026 to close at $7.56 on November 13, 2026.

What Should I Do?

At this stage, no lawsuit has been filed. The investigation is ongoing to determine whether claims may be brought under federal securities laws.

If you purchased or otherwise acquired NeuroPace securities, have information, or would like to learn more about this investigation, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below, to discuss your rights or interests with respect to these matters at no cost.

[LEARN MORE ABOUT YOUR RIGHTS AS AN INVESTOR]

Kirby McInerney LLP is a New York-based plaintiffs’ law firm concentrating in securities, antitrust, whistleblower, and consumer litigation. The firm’s efforts on behalf of shareholders in securities litigation have resulted in recoveries totaling billions of dollars. Additional information about the firm can be found on Kirby McInerney LLP’s website.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

Kirby McInerney LLP

NASDAQ:NPCE

Release Versions
$Cashtags

Contacts

Kirby McInerney LLP
Lauren Molinaro, Esq.
212-699-1171
https://www.kmllp.com
https://securitiesleadplaintiff.com/
investigations@kmllp.com

More News From Kirby McInerney LLP

CARDINAL INFRASTRUCTURE GROUP INC. INVESTIGATION: CDNL Securities Investors Encouraged to Contact Kirby McInerney LLP About Their Rights

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP is investigating potential claims against Cardinal Infrastructure Group Inc. (“Cardinal” or the “Company”) (NASDAQ: CDNL). The investigation concerns whether the Company and/or members of its senior management may have violated federal securities laws or engaged in other unlawful business practices. If you purchased or otherwise acquired Cardinal securities, please contact Lauren Molinaro of Kirby McInerney LLP by email at investigat...

Securities Class Action Filed Against Everest Group, Ltd. – EG Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Everest Group, Ltd. (“Everest” or the “Company”) (NYSE: EG) securities between February 8, 2024 and October 27, 2025, inclusive (“the Class Period”). If you suffered a loss on your Everest investments, you have until December 28, 2026 to request lead plaintiff appointment.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]Investors are encouraged to fill o...

Securities Class Action Filed Against Intel Corporation – INTC Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Intel Corporation (“Intel” or the “Company”) (NASDAQ: INTC) securities between July 23, 2026 and October 29, 2026, inclusive (“the Class Period”). If you suffered a loss on your Intel investments, you have until January 12, 2027 to request lead plaintiff appointment.[CONTACT THE FIRM IF YOU SUFFERED A LOSS]Investors are encouraged to fill out the...
Back to Newsroom